 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Imatinib Mesylate in Treating Patients With Recurrent Brain
Tumor
|
|
|
|
Phase II, Phase I
|
|
|
|
NCCTG-N0272
N0272, NCT00049127
|
|
| |
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
|
|
Phase II, Phase I
|
|
|
|
NABTC-0402
NCI-06-C-0053, NABTC-04-02, NCT00112736
|
|
| |
Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
|
|
|
|
Phase II, Phase I
|
|
|
|
SJCRH-SJHG04
GENENTECH-OSI3160s, NCT00124657
|
|
| |
A Phase I/II Study of the Photon Radiosurgery System
|
|
|
|
Phase II, Phase I
|
|
|
|
CNS 0201
NCT00179907
|
|
| |
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
|
|
|
|
Phase II, Phase I
|
|
|
|
UCSF-05103
05103, UCSF-H41995-27311-01, NCT00293423
|
|
| |
Combination Chemotherapy and Blood-Brain Barrier Disruption Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma
|
|
|
|
Phase II, Phase I
|
|
|
|
OHSU-8507
OHSU-2868, OHSU-SOL-04058-L, NCT00303849
|
|
| |
ZD6474 in Treating Patients With Recurrent or Progressive Gliomas
|
|
|
|
Phase II, Phase I
|
|
|
|
NCI-06-C-0063
NCI-P6680, NCT00293566
|
|
| |
High Dose CPT-11 in Recurrent Unresectable Malignant Glioma
|
|
|
|
Phase II, Phase I
|
|
|
|
1068114
44OE-ONC-0020-3, NCT00283556
|
|
| |
Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
R01 CA 89395-01
Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
|
|
| |
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
|
|
Phase II, Phase I
|
|
|
|
UCLA-0604104
OSI3781s, NCT00509431
|
|
